The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience

Chromogranin A (CgA) is a non-specific biomarker excreted by neuroendocrine tumor (NET) cells. Elevation of circulating CgA level can be detected in gastroenteropancreatic (GEP)-NET patients and has been shown to correlate with tumor burden. The prognostic and predictive roles of CgA level and the c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hui-Jen Tsai, Chin-Fu Hsiao, Jeffrey S. Chang, Li-Tzong Chen, Ying-Jui Chao, Chia-Ju Yen, Yan-Shen Shan
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/b5cd3260d8974337a47bcaa9143429fd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b5cd3260d8974337a47bcaa9143429fd
record_format dspace
spelling oai:doaj.org-article:b5cd3260d8974337a47bcaa9143429fd2021-11-12T05:02:22ZThe Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience2234-943X10.3389/fonc.2021.741096https://doaj.org/article/b5cd3260d8974337a47bcaa9143429fd2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.741096/fullhttps://doaj.org/toc/2234-943XChromogranin A (CgA) is a non-specific biomarker excreted by neuroendocrine tumor (NET) cells. Elevation of circulating CgA level can be detected in gastroenteropancreatic (GEP)-NET patients and has been shown to correlate with tumor burden. The prognostic and predictive roles of CgA level and the change of CgA level are controversial. In this study, we retrospectively analyzed 102 grade 1/2 GEP-NET patients with available baseline or serial follow-up CgA levels from the National Cheng Kung University Hospital to evaluate the association between circulating CgA level and the tumor extent, overall survival (OS), and tumor response prediction. The baseline characteristics, baseline CgA level, and change of CgA level during follow-up and their association was analyzed. Sixty cases had baseline CgA levels available prior to any treatment and ninety-four cases had serial follow-up CgA levels available during treatment or surveillance. Baseline CgA levels were associated with stage and sex. Higher baseline CgA levels were associated with worse OS after adjusting for sex, stage, grade, primary site, and functionality (hazard ratio=13.52, 95% confidence interval (CI), 1.06-172.47, P=0.045). The cross-sectional analysis for the change of CgA level during follow-up showed that a ≥ 40% increase of CgA meant a higher probability of developing tumor progression or recurrence than those with a < 40% increase of CgA level (odds ratio=5.04, 95% CI, 1.31-19.4, P=0.019) after adjusting for sex, age, grade, stage, and functionality. Our study results suggest that CgA may be a predictive marker for tumor burden, OS, and tumor progression in GEP-NET patients.Hui-Jen TsaiHui-Jen TsaiHui-Jen TsaiChin-Fu HsiaoJeffrey S. ChangLi-Tzong ChenLi-Tzong ChenLi-Tzong ChenYing-Jui ChaoChia-Ju YenYan-Shen ShanYan-Shen ShanFrontiers Media S.A.articlechromogranin Aneuroendocrine tumorsgastroenteropancreasprognostic factorpredictive factorNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic chromogranin A
neuroendocrine tumors
gastroenteropancreas
prognostic factor
predictive factor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle chromogranin A
neuroendocrine tumors
gastroenteropancreas
prognostic factor
predictive factor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Hui-Jen Tsai
Hui-Jen Tsai
Hui-Jen Tsai
Chin-Fu Hsiao
Jeffrey S. Chang
Li-Tzong Chen
Li-Tzong Chen
Li-Tzong Chen
Ying-Jui Chao
Chia-Ju Yen
Yan-Shen Shan
Yan-Shen Shan
The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
description Chromogranin A (CgA) is a non-specific biomarker excreted by neuroendocrine tumor (NET) cells. Elevation of circulating CgA level can be detected in gastroenteropancreatic (GEP)-NET patients and has been shown to correlate with tumor burden. The prognostic and predictive roles of CgA level and the change of CgA level are controversial. In this study, we retrospectively analyzed 102 grade 1/2 GEP-NET patients with available baseline or serial follow-up CgA levels from the National Cheng Kung University Hospital to evaluate the association between circulating CgA level and the tumor extent, overall survival (OS), and tumor response prediction. The baseline characteristics, baseline CgA level, and change of CgA level during follow-up and their association was analyzed. Sixty cases had baseline CgA levels available prior to any treatment and ninety-four cases had serial follow-up CgA levels available during treatment or surveillance. Baseline CgA levels were associated with stage and sex. Higher baseline CgA levels were associated with worse OS after adjusting for sex, stage, grade, primary site, and functionality (hazard ratio=13.52, 95% confidence interval (CI), 1.06-172.47, P=0.045). The cross-sectional analysis for the change of CgA level during follow-up showed that a ≥ 40% increase of CgA meant a higher probability of developing tumor progression or recurrence than those with a < 40% increase of CgA level (odds ratio=5.04, 95% CI, 1.31-19.4, P=0.019) after adjusting for sex, age, grade, stage, and functionality. Our study results suggest that CgA may be a predictive marker for tumor burden, OS, and tumor progression in GEP-NET patients.
format article
author Hui-Jen Tsai
Hui-Jen Tsai
Hui-Jen Tsai
Chin-Fu Hsiao
Jeffrey S. Chang
Li-Tzong Chen
Li-Tzong Chen
Li-Tzong Chen
Ying-Jui Chao
Chia-Ju Yen
Yan-Shen Shan
Yan-Shen Shan
author_facet Hui-Jen Tsai
Hui-Jen Tsai
Hui-Jen Tsai
Chin-Fu Hsiao
Jeffrey S. Chang
Li-Tzong Chen
Li-Tzong Chen
Li-Tzong Chen
Ying-Jui Chao
Chia-Ju Yen
Yan-Shen Shan
Yan-Shen Shan
author_sort Hui-Jen Tsai
title The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
title_short The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
title_full The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
title_fullStr The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
title_full_unstemmed The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center Experience
title_sort prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors – a single-center experience
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b5cd3260d8974337a47bcaa9143429fd
work_keys_str_mv AT huijentsai theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT huijentsai theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT huijentsai theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT chinfuhsiao theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT jeffreyschang theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT litzongchen theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT litzongchen theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT litzongchen theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT yingjuichao theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT chiajuyen theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT yanshenshan theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT yanshenshan theprognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT huijentsai prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT huijentsai prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT huijentsai prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT chinfuhsiao prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT jeffreyschang prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT litzongchen prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT litzongchen prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT litzongchen prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT yingjuichao prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT chiajuyen prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT yanshenshan prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
AT yanshenshan prognosticandpredictiveroleofchromograninaingastroenteropancreaticneuroendocrinetumorsasinglecenterexperience
_version_ 1718431192474189824